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Abstract 
Fatigue is common and debilitating in Rheumatoid Arthritis (RA). A focus on the 
psychological variables associated with fatigue may help to identify targets for intervention 
which could enhance the treatment of fatigue in RA. The purpose of this review was to 
systematically identify psychological variables related to fatigue in RA, with the overall aim 
of suggesting evidence-based targets for fatigue intervention in RA. Twenty-nine studies met 
inclusion criteria and were included in the narrative synthesis. A wide range of psychological 
variables were addressed, spanning 6 categories: affect and common mental disorders; RA-
related cognitions; non-RA-related cognitions; personality traits; stress and coping; and social 
support/interpersonal relationships. The most consistent relationship was found between 
mood and fatigue, with low mood frequently associated with increased fatigue. Some 
evidence also highlighted the relationship between RA-related cognitions (such as RA self-
efficacy) and fatigue, and non-RA-cognitions (such as goal ownership) and fatigue. Limited 
evidence was found to support the relationship between stress and coping or personality traits 
and fatigue, although mixed evidence was found for the relationship between social support 
and fatigue. The results of this review suggest the interventions for fatigue in RA may benefit 
from a focus on mental health, and disease-related cognitions.  
Keywords: fatigue, Rheumatoid Arthritis, psychological, mood, cognitions, social support, 
stress, coping, personality, intervention, systematic review.  
  
Introduction 
Rheumatoid Arthritis (RA) is a chronic autoimmune disease which affects 0.2-1.2% of the 
adult population (Alamanos, Voulgari, & Drosos, 2006). RA is progressive and primarily 
affects the joints, leading to increased pain, functional disability and joint destruction (Kvien, 
2004). In addition to the impact RA has on joints and physical disability, there are other 
extra-articular manifestations which can also contribute to poor patient outcomes.  RA 
significantly impacts quality of life, with RA patients showing notably lower fatigue-related 
quality-of-life in comparison to the general population (Matcham et al., 2014). Fatigue is 
reported in over 80% of RA patients (Belza, Henke, Yelin, Epstein, & Gilliss, 1993; Belza, 
1995; Pollard, Choy, Gonzalez, Khoshaba, & Scott, 2006). More conservative estimates are 
still high: approximately 40% of RA patients experience persistent fatigue over one year 
(Repping-Wuts, Fransen, Van Achteberg, Bleijenberg, & Van Riel, 2007) and 57% of RA 
patients identify fatigue as the most problematic symptom of their condition (Wolfe, Hawley 
& Wilson 1996).  
Fatigue is often experienced in healthy people (Pawlikowska, Chalder, Hirsch, Wallace, 
Wright, & Wessely, 1994); it is usually transient and can be caused by a lack of sleep or high 
stress levels (Loge, Ekeberg, & Kaasa, 1998).  In the general population, fatigue is a 
universal symptom, existing on a spectrum of severity and chronicity, at one end of which 
patients have persistent fatigue, contributing to substantial impairment. Qualitative studies 
have revealed that despite fatigue being the most problematic symptom for the majority of 
patients with RA, patients’ experiences are that this is often dismissed by healthcare 
professionals (Hewlett et al., 2005). Furthermore, despite the high prevalence of fatigue in 
RA, and the clear impact fatigue has on patients’ well-being, fatigue is infrequently reported 
in RA trials (Kalyoncu, Dougados, Daurès, & Gossec, 2009). Fatigue in RA tends to be 
chronic and is associated with increased levels of pain and depression, and reduced functional 
status and quality-of-life (Rupp, Boshuizen, Jacobi, Dinant, & van den Bos, 2004; Mayoux-
Benhamou 2006; van Hoogmoed, Fransen, Bleijenberg, & van Riel, 2010).  
A recent review examining variables relating to fatigue in RA found that the most consistent 
relationships were between fatigue and pain, disability and depression (Nikolaus, Bode, Taal, 
& van de Laar, 2013). Whilst this review examined a broad range of variables relating to 
fatigue, there was limited focus on social and behavioural variables. In their guidelines for the 
for management of early rheumatoid arthritis, Luqmani et al. (2006) report that the strong 
associations between fatigue and reduced quality-of-life and increased work dysfunction 
highlight a need for further research establishing the course of fatigue in RA and developing 
effective treatment strategies for fatigue management.   
Meta-analysis evidence suggest that biotherapies have small-to-moderate effects on fatigue 
outcomes (Chauffier, Salliot, Berenbaum, & Sellam, 2012). This systematic review found an 
overall effect size of 0.45 (95%CI: 0.31-0.58) when comparing all disease modifying RA 
drugs with placebo. There is currently no systematic review examining the impact of other 
pharmacological interventions (such as antidepressants) on fatigue outcomes in RA.  
Psychological factors may also be help to identify patients at risk of reduced fatigue 
biotherapy response (Druce, Jones, Macfarlane, & Basu, 2014). A focus on the psychological 
variables associated with fatigue may be crucial not only for developing psychological 
interventions for fatigue, but also for identifying patients who may not benefit from 
traditional biotherapy for fatigue.   
There is some evidence to suggest that psychological interventions may improve fatigue 
outcomes (Hewlett et al., 2011a; Cramp et al., 2013). A conceptual, dynamic model of fatigue 
incorporating disease-related factors (such as inflammation and medication), personal factors 
(social support and work environment), and cognitive behavioural factors (including thoughts 
and feelings), has been developed (Hewlett et al., 2011b). However in comparison to other 
physical conditions, there has been limited systematic assessment of the psychological 
variables associated with fatigue in RA, and until such a review is conducted, the most useful 
target variables for intervention in this population remain unknown. 
The aim of this review is to identify studies assessing psychological factors which may be 
associated with, predict or explain fatigue outcomes in RA. The aims are: a) to ascertain the 
strength of evidence for relationships between psychological variables and fatigue in RA; b) 
to map identified psychological variables onto commonly used models of chronic fatigue, in 
an attempt to clarify the most useful target variables for interventions; and c) to identify 
methodological issues and gaps in literature the with the aim to advise the direction of future 
research. For the purposes of this review, psychological factors are defined as variables 
which relate to behaviours, feelings, thoughts and attitudes which would be modifiable for 
the purposes of intervention, or which may moderate the effects of treatment.  
Method 
Search Strategy and Selection Criteria 
The systematic review protocol and data extraction forms were designed in accordance with 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (Moher, Liberati, 
Tetzlaff, & Altman, 2009). Electronic databases (PsychINFO, Web of Science, MEDLINE, 
EMBASE, CINAHL) were systematically searched from inception to March 2013, using 
customised search terms for each database. Search terms involved combining key word 
searches for fatigue (“Fatigue” or “tiredness”), the terms “determine$”, “predict$” or 
correlate$”, and “Rheum*” or “Rheumatoid Arthritis”.  
Inclusion and Exclusion Criteria 
Included studies met the following criteria: (i) observational design, or baseline cross-
sectional data from a trial; (ii) published quantitative studies examining psychological factors 
relating to fatigue in RA; (iii) reported results for RA separately from other rheumatological 
conditions. 
 
Studies were excluded if they: (i) used qualitative, case-series, case-reports, expert opinion or 
consensus statements; (ii) used a selective sample (e.g., intervention trials); (iii) did not use 
published/appropriate and replicable measures to assess psychological factors and fatigue; 
(iv) did not report fatigue as the outcome variable in a regression analysis; (v) recruited 
patients with self-reported RA diagnosis. Where multiple publications came from the same 
group of researchers and same patient group, data were retained for uniquely assessed 
psychological variables. That is, if two studies represented the same patient group and one 
examined fatigue and depression, and the other examined fatigue and social support, then 
data from both papers were included. To increase the external validity of our results, studies 
using selective samples (interventions and randomised controlled trials) were excluded. 
These designs typically stipulate rigorous eligibility criteria (such as limited comorbidities 
and high disease activity), which may limit the generalizability of their results to the general 
RA patient population (Rothwell, 2005).  
 
A post-hoc decision was made to exclude studies measuring quality-of-life (QoL) in relation 
to fatigue, as QoL was not deemed a modifiable psychological variable. However due to the 
content similarities between the Mental Health subscale of the Medical Outcomes Study 36-
item Short-Form Health Survey (SF-36, a measure of general QoL; Ware & Sherbourne, 
1992) and other validated mental health screening tools, it was decided that studies reporting 
associations between mental health QoL would be included as potentially modifiable 
psychological constructs.  
Data Extraction 
Study titles then abstracts were screened by two research assistants, in collaboration with one 
researcher (FM). The full texts were then screened by FM and all ineligible papers were 
excluded. Information from each eligible study was extracted and tabulated. Extracted data 
included country of origin, study design, data analysis methodology, sample characteristics, 
relevant measures, main findings, and aspects of methodology quality. The extraction process 
was completed independently by two researchers, FM and SA, and any disagreements 
resolved through discussion of the study with TC. Where only abstracts were available, or 
insufficient information was reported, authors were contacted via email. Only one paper was 
excluded due to insufficient information being reported and the author remaining un-
contactable (Figure 1).  
Data Synthesis 
The heterogeneity of the included studies and broad nature of the review aim precluded meta-
analysis.  
Psychological variables were grouped into overarching categories, representing conceptually 
or thematically comparable constructs. A box-score method was used to quantify the 
relationships between the identified psychological variables and fatigue. This method 
involves tabulating each variables and its relationship with fatigue, in terms of significance 
and direction: a positive sign (+) was given for a positive significant association between 
variables; a negative sign (-) for a negative significant association between variables; and a 
nought (0) for no association between variables (Green & Hall, 1984). This table also takes 
into account the study design (cross-sectional or longitudinal) and level of analysis (bivariate 
or multivariate). Thus tabulated associations could be synthesised alongside indicators of 
study quality. Data from all analyses are included in the box-score table, meaning that data 
from both bivariate and multivariate models are included, in order to retain as much data for 
comparison as possible.   
Elements of study quality were also assessed, selected from a previously used quality-
assessment tool (Matcham et al., 2013), to be applicable for both cross-sectional and 
longitudinal study designs. These included: whether the psychological variable of interest 
was measured using a validated tool; whether fatigue was measured using a multi-item 
questionnaire (as opposed to a VAS); whether the recruitment strategy was 
randomised/consecutive; whether the participants were recruited from multiple centres 
(representing multiple locations, not just multiple centres within the same city, for example); 
whether eligibility criteria were specified; whether participation rate was greater than 75%; 
whether the study was adequately powered. Where studies did not report anything for a 
particular eligibility indicator, they were allocated to the “No” category.  
Results 
In the following results section, we present the following information: 
1. Results of the systematic search and characteristics of included studies.  
2. Description of the identified psychological variables and allocation into 
categories. 
3. Affect and common mental disorder 
4. RA-related cognitions 
5. Non-Ra-related cognitions 
6. Personality Traits 
7. Stress and Coping 
8. Social Support and Interpersonal relationships 
 
Search Results/Study Characteristics 
The literature search yielded 3,387 relevant articles (Figure 1). Removal of duplicates, title 
and abstract screening left 218 articles for full-text screening. One hundred and eighty nine of 
these did not meet our eligibility criteria. The most common reason for exclusion was for not 
having measured or reported eligible psychological variables. Twenty-nine studies were 
deemed eligible for inclusion in the narrative synthesis.  
 
Figure 1. Flow chart of the selection of relevant studies  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
189 studies excluded 
-103 no psychological variables 
measured 
-29 no analysis between fatigue and 
psychological variable 
-14 RA results not reported 
separately from other 
rheumatological conditions 
-12 duplicates 
-12 ineligible study design 
-11 ineligible measurement of 
fatigue 
-5 ineligible measure of 
psychological variables.  
- 2 unusable data analysis 
- 1 text unable to access 
 
29 studies included in 
narrative synthesis 
Full texts screened  
218 
Studies removed: 
115 
Abstracts screened 
333 
Studies removed: 
2,336 
Titles screened 
2,669 
Duplicates removed:  
718 
Total search 
3,387 
PsychInfo 
1,501 
Web of Science 
670 
Medline 
280 
Embase 
886 
Cinahl 
50 
Table 1. Studies included in narrative synthesis 
 
Author, year (ref.) Sample (country, 
population, gender) 
Setting, recruitment 
strategy 
Study Design, 
analysis method 
Fatigue measurement Psychological variables 
Barlow 2002 UK,                           
N = 60,                   
Mean age: 59.2 (11.3)                  
86.7% female             
Mean disease duration 
(years): 16.9 (13.7)                 
Rheumatology 
outpatients, 
consecutive 
recruitment 
Longitudinal, 
Pearson's product 
moment.  
VAS, 100mm horizontal line 
anchored 0 (no fatigue) and 10 
(fatigue as bad as it could be).  
Depression (HADS)   
Anxiety (HADS)       
 Illness acceptance (AIS)   
Self-efficacy (ASES)           
Positive affect (PANAS)     
Negative affect (PANAS)  
Belza 1993 USA,                          
N = 133,                   
Mean age: 67.0 (6.6)         
75.0% female           
Mean disease duration 
(years): 18.0 (10.5)               
Arthritis Research 
Centre, "selected" 
Cross-sectional, 
hierarchical 
multiple 
regression 
analysis 
MAF Depression (GDS)                  
Arthritis Helplessness 
(AHI) 
Belza 1995 USA,                          
N = 51,                   
Mean age: 43.6 (8.9)         
75.0% female            
Mean disease duration 
(years): 10.7 (8.3)               
Rheumatology 
outpatients,  
recruitment strategy 
NS 
Longitudinal, 
Pearson's 
correlation 
MAF Depressed mood (POMS) 
Brekke 2003 Norway,                          
N = 306,                   
Mean age: 53.3 (11.4)                    
80.4% female            
Mean disease duration 
(years): 11.0 (9.3)                
Oslo RA register Longitudinal, 
Pearson's 
correlation 
VAS, 100mm horizontal line 
anchored 0 (no fatigue) and 10 
(fatigue as bad as it could be).  
Self-efficacy (ASES)         
Affect (AIMS2)                   
Mental Health (SF-36)                   
Covic 2006 Australia,                          
N = 134,                   
Mean age: 58.5 (11.9)                     
77.0% female              
Mean disease duration 
(years): 13.2 (9.5)                  
Rheumatology clinics, 
convenience sampling 
Cross-sectional, 
discriminant 
analysis 
VAS, 100mm horizontal line 
anchored 0 (no fatigue) and 10 
(fatigue as bad as it could be).  
Depression (CESD) 
Cross 2008 Australia,                          
N = 52,                   
Mean age: 65.5 (12.4)                 
79.0% female             
Mean disease duration 
(years): 26.0 (10.8)              
Rheumatology 
outpatients,  
convenience sampling 
Cross-sectional, 
Spearman 
correlations, 
regression 
analysis 
FSS, MAF Self-efficacy (ASES)                            
Mental Health (SF-36)                   
Davis 2010 USA,                           
N = 228,                   
Mean age: 55.3 (13.2)                
69.3% female             
Mean disease duration 
(years): 13.4 (13.1)                 
Advertising, 
convenience sampling 
Follow-up, multi-
level modelling 
VAS, 0 (no fatigue) to 100 
(fatigue as bad as it can be). 
Daily interpersonal events 
(daily diaries, ISLE)                           
Positive affect (PANAS)     
Negative affect (PANAS) 
Fifield 1998 USA,                           
N = 227,                   
Mean age: 55.5 (10.0)                 
78.0% female         
Mean disease duration 
(years): 17.0 (8.0)             
National Rheumatoid 
Arthritis Panel study, 
"selected"  
Cohort, ANOVA VAS, 0 (no fatigue) to 100 
(fatigue as bad as it can be). 
Depression (DIS for DSM-
III)                                       
Dysphoria (CESD) 
Huyser 1998 USA,                           
N = 73,                   
Mean age: 59.3 (10.6)                 
54.8% female      
Mean disease duration 
(years): 12.9 (9.7)             
Longitudinal study, 
convenience sampling 
Cross-sectional, 
Spearman 
correlations, best 
regression model 
derivation 
Piper Fatigue Scale Self-efficacy (ASES)       
Arthritis impact (AIMS)    
Depressed mood (CESD)    
Psychological distress 
(SCL-90)                            
Stress (DSI)                          
Hassles (HS)                        
Anxiety (STAI)                        
Coping (CSQ) 
Ibn Yacoub 2012 Morocco,                          
N = 248,                   
Mean age: 47.5 (79.0)                     
79.0% female       
Mean disease duration 
(years): 10.6 (8.1)              
Rheumatology 
outpatients,  
recruitment strategy 
NS 
Cross-sectional, 
Pearson's 
correlation, 
multiple linear 
regression model 
VAS, 100mm horizontal line 
anchored 0 (no fatigue) and 10 
(worst fatigue imaginable).  
Mental Health (SF-36) 
Jump 2004 USA,                                 
N = 122                                                          
Mean age: 59.9 (9.7)            
92.6% female                       
Mean disease duration 
(years): 21.0 (8.3)    
National Rheumatoid 
Arthritis Panel study, 
"selected"  
Cohort, Pearson's 
correlation.  
MAF, GFI History of mood disorder 
(depression/anxiety)         
(DSM-IV)                              
Neuroticism (NEO)                 
Self-efficacy (ASES) 
Maes 2012 The Netherlands,                          
N = 129,                                        
NS Longitudinal, 
hierarchical 
regression 
analysis 
CIS-20 Goal ownership (TSRQ)      
Self-efficacy (SRSB) 
Mancuso 2006 USA,                           
N = 122,                   
Mean age: 49.0 (12.0)                     
84.0% female                      
Rheumatology 
practices,  recruitment 
strategy NS 
Cross-sectional, 
multivariate 
regression 
analysis 
FSS Anxiety (STAI)                
Depression (GDS)               
Social support/social stress 
(DSSS)                                  
Role satisfaction (Likert 
scale 1-5)  
Neame 2005 UK,                           
N = 344,                            
67.0% female            
Median disease 
duration (years): 13.3 
(6.0-25.0)                         
DMARD monitoring 
database, "selected" 
Cross-sectional, 
Bivariate, partial 
correlations 
VAS Beliefs about medications 
(BMQ)                 
Psychological distress 
(VAS)                   Attitudes 
(RAI)                     
Nicklin 2010 UK,                          
N = 229,                            
76.4% female                  
Rheumatology 
outpatients, 
consecutive 
recruitment 
Cross-sectional, 
Spearman 
correlations 
BRAF, FACIT-F, MAF, 
POMS, SF-36 
Depression (HADS)             
Anxiety (HADS)                 
Helplessness (AHI) 
Pollard 2006 UK,                           
N = 274,                   
Mean age: 64.0                 
Mean disease duration 
(years): 12.0                   
Rheumatology 
outpatients,  
recruitment strategy 
NS 
Cross-sectional, 
multiple 
regression 
VAS, 100mm horizontal line  Mental Health (SF-36) 
Rezvani 2012 Turkey,                          
N = 50,                   
Mean age: 50.6 (8.9)    
90% female           
Mean disease duration 
(years): 9.2 (6.0)                   
NS Cross-sectional, 
correlation 
analysis 
VAS Depression (HADS)             
Anxiety (HADS)                 
Illness Perceptions (BIPQ) 
Riemsma 1998 The Netherlands,                          
N = 229,                   
Mean age: 63.3 (11.7)                 
61.0% female                    
Mean disease duration 
(years): 18.7 (10.6)                     
Rheumatology 
outpatients, 
consecutive 
recruitment 
Cross-sectional, 
linear regression 
VAS Affect (AIMS)                         
Social Support (SSLI2-I)                              
Self Efficacy (ASES)              
Self-efficacy expectations 
(SMS) 
Rupp 2004 The Netherlands,                          
N = 400,                   
Mean age: 60.7 (13.4)                     
72.7% female                  
Mean disease duration 
(years): 10.7 (9.2)                     
Rheumatology 
outpatients,  
recruitment strategy 
NS 
Cross-sectional, 
Spearman's 
correlation  
VAS, MFI Depression (CESD) 
Stebbings 2010 New Zealand,                          
N = 103,                   
Mean age: 58.4 (12.2)                     
70.9% female                       
Mean disease duration 
(years): 14.8 (12.7)                      
Rheumatology 
outpatients, 
consecutive 
recruitment 
Cross-sectional, 
linear regression 
MAF Depression (HADS)             
Anxiety (HADS)                  
Stone 1997 USA,                           
N = 35,                   
Mean age: 52.4 (12.3)    
71.4% female                      
Rheumatology 
practices, convenience 
sampling 
Follow-up, OLS 
regression, 
RMANOVA 
Ecological Momentary 
Assessment 
Anxiety (STAI)                 
Thyberg 2009 Sweden,                          
N = 276,                   
Mean age: 54.0 (14.0)    
69.2% female                      
Multi-centre project, 
randomised sampling 
Longitudinal, 
multiple linear 
regression 
VAS Mental Health (SF-36) 
Treharne 2005 UK,                          
N=154                               
Mean age = 56.3 (15.1)                                      
73.0% female                            
Rheumatology 
outpatients,  
recruitment strategy
NS 
Cross-sectional, 
correlation 
analysis 
VAS RA control/cure (IPQ) 
Beliefs about medications 
(BMQ)                                   
Optimism/Pessimism 
(LOT)                                   
Self-Consciousness (SCS)                           
Social Support (SSS)               
Anxiety (HADS)           
Treharne 2007 UK,                           
N = 129,                   
Mean age: 55.4 (14.3)                   
75.0% female                      
Rheumatology 
outpatients, 
consecutive 
recruitment 
Cross-sectional, 
Spearman's 
correlation  
VAS Perceived stress (PSS) 
Treharne 2008 UK,                          
N = 114,                   
Mean age: 55.8 (14.5)                  
73.7% female                      
Rheumatology 
outpatients,  
recruitment strategy 
NS 
Longitudinal, 
hierarchical 
linear regression 
VAS, 100mm horizontal line 
anchored "no fatigue" and 
"unbearable fatigue".  
Depression (HADS)           
RA consequences (IPQ)                         
Self-Efficacy (ASES)              
Coping (CSQ) 
van Hoogmoed 2012 The Netherlands,                          
N = 228,                   
Mean age: 55.9 (10.8)                
63.0% female              
Median disease 
duration (years): 10.0 
(6-17)                     
Rheumatology 
outpatients,  
recruitment strategy 
NS 
Cross-sectional, 
backward 
multiple 
regression 
CIS-20 Depression (BDI-pc)          
Psychological Distress 
(SCL-90)                      
Mental Health (SF-36)            
Self-esteem (RSE)           
Optimism (LOT)              
Attributions (CAL)        
Self-efficacy (SES-28)        
Coping (MPCI)              
Catastrophising (FCS) 
Waltz 2000 Germany & The 
Netherlands,                          
N = 234,                   
Mean age: 58.5     
69.0% female         
Median disease 
duration (years): 10.0                             
Rheumatology 
outpatients, 
consecutive 
recruitment 
Longitudinal, 
correlation 
anlysis 
CFIF Depression (CESD) 
Wolfe 1996 USA,                           
N = 628,                   
Mean age: 61.9     
74.7% female            
Median disease 
duration (years): 10.0 
(6.5-17.9)    
Rheumatology 
outpatients, 
consecutive 
recruitment 
Cross-sectional, 
multivariate 
regression 
analysis 
VAS, anchored "fatigue is no 
problem" and "fatigue is a 
major problem".  
Anxious mood (AIMS)               
Depressed mood (AIMS)        
Wolfe 2004 USA,                           
N = 21,076,                   
Mean age: 54.6 (11.4)                      
79.7% female       
Mean disease duration 
(years): 13.7          
Data bank Cross-sectional, 
multiple 
regression 
VAS, anchored "fatigue is no 
problem" and "fatigue is a 
major problem".  
Anxious mood (AIMS)               
Depressed mood (AIMS)  
NS = Not Stated; VAS = visual analogue scale; HADS = Hospital Anxiety and Depression Scale; AIS = Arthritis Illness Acceptance Scale; ASES = Arthritis Self-Efficacy Scale; PANAS = Positive and Negative 
Affect Scale; MAF = Multi-Dimensional Assessment of Fatigue; GDS = Geriatric Depression Scale; AHI = Arthritis Helplessness Index; POMS = Profile of Mood States; AIMS2 = Arthritis Impact Scale 2; SF-36 = 
Medical Outcomes Study 36-item Short-Form Health Survey; CESD = Centre for Epidemiological Studies Depression Scale; FSS = Fatigue Severity Scale; ISLE = Inventory of Stressful Life Events; DIS = Diagnostic 
Interview Schedule; DSM-II = Diagnostic and Statistical Manual III; SCL-90 = 90-item symptom checklist; DSI = Daily Stress Inventory; HS = Hassles Scale; STAI = State Trait Anxiety Inventory; CSQ = Coping 
Strategies Questionnaire; ANOVA = Analysis of Variance; TSRQ = Treatment Self-Regulation Questionnaire; SRSB = Self-regulation Skills Battery; CIS-20 = Checklist Individual Strength; DSSSS = Duke Social 
Support and Stress Scale; BMQ = Beliefs about Medications Questionnaire; RAI = Rheumatology Attitudes Index; BRAF = Bristol Rheumatoid Arthritis Fatigue; FACIT-F = Functional Assessment of Chronic Illness 
Therapy-Fatigue; (B)IPQ = (Brief) Illness Perceptions Questionnaire; BDI-pc = Beck Depression Inventory for Primary Care; RSE = Rosenberg Self-Esteem scale; LOT = Life Orientation Test; CAL = Causal 
Attribution List; SES-28 = Self-Efficacy Scale-28; MPCI-F = Modified Pain Coping Inventory for Fatigue; FCS = Fatigue Catastrophising Scale.  
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Table 1 presents the 29 studies included in the review. The most common method of 
measuring fatigue was through visual analogue scale (VAS), used by 17 (58.6%) studies. The 
Multidimensional Assessment of Fatigue (MAF; Neuberger, 2003) was the second most 
frequently used tool, used by 5 (17.2%) studies. The studies represented 26,388 individuals 
with RA. Sample sizes ranged from 35 to 21,076, and the median sample size was 154 
(interquartile range (IQR) = 114-248). The median of mean age was 56 (IQR = 53-59). The 
median percentage of females represented in the sample was 75% (IQR= 69%-79 %). The 
median of mean disease duration was 13.4 years (IQR= 11.0 years – 17.0 years), and the 
most frequent setting for patient recruitment was outpatient clinics, with 18 (62.1%) studies 
recruiting from them. Only 17 (58.6%) reported a recruitment strategy, and only eight 
(27.6%) used a random or consecutive recruitment strategy.  
Identified Psychological Variables 
A summary of the psychological variables identified and the number of studies examining 
each variable is shown in figure 2. In total, 25 different psychological variables were 
examined, which were categorised into six broad categories. Affect and common mental 
disorder included mental health-related variables, incorporating both identification of 
depression/anxiety disorders via validated screening tools or diagnostic interview, as well as 
more generalised elements of psychological distress, mental health, affect and self-esteem. 
Depression (N=17) was most commonly reported, with anxiety (N=10) being the second 
most commonly reported variable from this category.  
RA-related cognitions included variables such as self-efficacy, arthritis helplessness, illness 
perceptions, medication beliefs and illness acceptance. Disease self-efficacy was the most 
commonly-reported variable (N=8), followed by illness perceptions (N=3). Non-RA related 
cognitions were defined as variables which were related to cognitive processes unrelated to 
having a physical illness. This category included other types of self-efficacy (social-
mobilisation and fatigue-related), as well as role satisfaction, goal ownership, catastrophizing 
and fatigue attributions. Neuroticism was the most commonly assessed personality trait 
(N=3), and stress and coping mechanisms were included in a stress and coping category. 
Finally, the social support and interpersonal relationships category contained data relating to 
social mechanisms.  
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Figure 2. Graph of identified psychological variables. 
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Table 2. Box analysis of psychological variables examined in relation to fatigue. 
Variables associated with fatigue outcomes in RA.  
Category Factor   Cross-sectional 
 
Longitudinal/follow-up 
      Bivariate Multivariate   Bivariate Multivariate 
Affect and 
common mental 
disorder 
Depression 
 +,+,+,+,+,+,+,+,
+,+,+,+,+,+,+? 0,0,+,+,+,+ 
 
0,+ 0,0,0 
Anxiety 
 +,+,+,+,+,+,+,+,
+ 0,0,0 
 
+ +,0 
Mental Health 
 
-,-,-,- 0,0,- 
 
-,- - 
Psychological 
Distress  
 
+ + 
 
  
Affect 
 
0,+ 0,0 
 
+ 
 
Self-Esteem 
 
- 0 
 
  
RA-related 
cognitions 
Self-Efficacy 
Pain  
- 
 
   
Other 
symptoms -,- 0 
 
+ + 
General  -,- -,- 
 
  
Function - 0 
 
  
Coping with 
RA - - 
 
  
Helplessness 
 
+ 0 
 
  
Illness 
Perceptions 
Control/Cure 
+ 
 
   
Consequences 
+,+ 
 
 + + 
Not specified 
+ 
 
   
Medication 
Beliefs 
Necessity 
0,+ 
 
   
Concerns 
0,+ 
 
   
Illness 
Acceptance 
 
- 0 
 
  
Non-RA-related 
cognitions 
Goal 
Ownership 
 
    + 
Role 
Satisfaction 
 
- 
 
 - 0 
Fatigue self-
efficacy 
 
-,- - 
 
- - 
Fatigue causal 
attributions 
Somatic 
- 0 
 
  
Non-somatic 
+ 0 
 
  
Fatigue 
catastrophizing 
Rumination 
+ 0 
 
  
Helplessness 
+ 0 
 
  
Magnification 
+ - 
 
  
Social 
Mobilisation 
self-efficacy 
 
- - 
 
  
Neuroticism  
 + 0 
 
 0 
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Personality 
Traits 
Optimism 
 
0,- 0 
 
  
Pessimism 
 
0 
 
   
Self-
consciousness 
Public 
+ + 
 
  
Private 
0 0 
 
  
Stress and 
Coping 
Stress/Hassles 
 
+,+,+ 
 
 0 0 
Coping 
General  
0 
 
   
Worrying 
+ + 
 
  
Praying/Hoping 
0 
 
 0 0 
Retreating 
+ 0 
 
  
Resting 
+ 0 
 
  
Transformation 
+ 0 
 
  
Distraction 
0 
 
   
Reducing 
demands + 0 
 
  
Social Support 
and 
Interpersonal 
relationships 
Social Support Perceived 
quantity -,- 0 
 
0 0 
Problematic 
+,+ 0,+ 
 
  
Structural 
 
0 
 
  
Discrepancies 
0 
 
   
Perceived 
Adequacy 0,- 
 
   
Interpersonal 
Events 
Negative 
+ ? 
 
+ ? 
Positive ? ?   ? ? 
+ positive association with fatigue (p<0.05); - negative association with fatigue (p<0.05); 0 no association with fatigue 
(p<0.05); ? Mixed results 
 
Affect and Common Mental Disorders  
Psychological variables examining aspects of psychological well-being, depression, anxiety, 
mood or affect were assigned to this group. These variables range from clinically diagnosed 
depression, to constructs of affect and self-esteem, covering a wide spectrum of mental health 
states. Twenty-five studies examined associations between mood and common mental 
disorders and fatigue, nineteen using cross-sectional design, and 6 using prospective design. 
The results of the box-analysis of negative affect and common mental disorder are shown in 
Table 2. At a cross-sectional level, 93.9% (31/33) found significant associations between 
their affect and common mental disorder variables and fatigue. Increased levels of 
depression, anxiety and psychological distress, and reduced mental health were all found to 
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be bivariately associated with increased levels of fatigue. The correlation coefficient values 
for this association ranged between 0.15 (Barlow et al., 2002; negative affect) and 0.79 (Ibn 
Yacoub et al., 2012; mental health). One study (Fifield et al., 1998), found mixed results at a 
bivariate level. The authors report that neither a lifetime diagnosis of major depressive 
disorder (identified via a diagnostic interview schedule (Robins & Helzer, 1985), nor sub-
threshold major depression was significantly associated with current fatigue experience. 
However, regardless of history of mood disorder, patients experiencing current dysphoria 
reported significantly higher levels of fatigue than patients not experiencing current 
dysphoria. This suggests that it is current, rather than previous mood, which is the most 
reliably associated with experiences of fatigue. 
At a multivariate level, most depression and psychological distress retained their significant 
associations, whereas none of the anxiety, negative affect and self-esteem variables retained a 
level of statistical significance. Only 37.5% (6/16) results were statistically significant. No 
clear pattern emerges when considering the covariates included in the multivariate analyses, 
which could account for the reduction in effect size. Wolfe et al. (1996) found that anxiety 
and depression were both associated with increased fatigue in bivariate analyses (rs = 0.52 
and 0.50 respectively). After including age, sex, body mass index, smoking, sleep 
disturbance, pain, physical disability, morning stiffness, grip strength, joint count, 
inflammation, depression, night pain and disease duration (anxiety was omitted due to its 
collinearity with depression), depression remained a significant predictor of increased fatigue 
(= 0.14, p<0.001). Approximately 45% of the variance in fatigue in RA was found to be 
accounted for by pain, sleep disturbance and depression. By contrast, Riemsma et al. (1998)  
found that although mood was significantly associated with fatigue in a correlational analysis 
(0.45, p<0.001), a stepwise regression analysis including gender, disease duration, physical 
function, pain, social support and self-efficacy, resulted in mood being stepped out for the 
model at an early stage, with no multivariate effect size reported.  
Consideration of the longitudinal studies reveal a similar pattern of events. At a bivariate 
level, 83.3% (5/6) bivariate analyses report significant longitudinal associations between 
affect and common mental disorder and fatigue outcomes.  Only 33.3% (2/6) sustain 
significant associations after multivariate analysis.  Thyberg, Dahlström, & Thyberg (2009) 
assessed fatigue in early RA patients across three years.  Mental health was associated with 
fatigue consistently across time-points.  A principal components analysis was performed for 
male and female patients separately to identify underlying components in fatigue across three 
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yearly measurements.  For women, mental health was included in a component (also 
including sleep disturbance, activity limitation and pain) which accounted for 15% of the 
variance in fatigue at 12 and 24-month follow-ups, and 16% at 36-month follow-up. In men, 
the component including mental health was only included at 12- and 36-month follow-ups, 
and accounted for 26% and 17% of the variation in fatigue respectively. In a correlation 
analysis, Treharne et al. (2008) found that baseline depression was significantly associated 
with baseline fatigue and fatigue at 1-year follow-up. However in a hierarchical linear 
regression, depression was added into a model that included several demographic (age, sex, 
employment status) and clinical (disease duration, medication, inflammation, pain and 
disability) variables, and the association was rendered non-significant. 
The weight of evidence provided here suggests that while negative affect and common 
mental disorders may have significant implications for fatigue at a bivariate level, this 
relationship tends to be lost at a multivariate level. There are differences between the 
variables in this category, with depression and anxiety being more frequently reported than 
other variables such as mental health, general psychological distress, negative affect and self-
esteem. Additionally, there appear to be differential relationships between these variables, 
with depression and distress more frequently associated with fatigue than negative affect and 
anxiety.  
Examination of the quality summary shown in Table 3 shows that the studies in the affect and 
common mental disorder category are of mixed quality. Whilst the majority use validated 
measures of their respective psychological variables (76%), and most reported sufficient 
eligibility criteria (80%), only 52% used validated, multi-item measures of fatigue. 
Additionally, only 32% utilised a randomised or consecutive recruitment strategy, and 36% 
were multi-centre studies and had a reported participation rate of >75%. Only 20% of studies 
overtly stated that they had sufficient power for their analysis, which may account for why so 
many affect and common mental disorder variables were no longer significant at a 
multivariate level.  
RA-related cognitions 
Twelve studies examined fatigue in relation to RA cognitions. RA cognitions relate to 
perceptions or thoughts related to RA, which may be associated with poorer health outcomes. 
The common sense model of illness (Leventhal, Nerenz, & Steele, 1984) suggests that when 
faced with a health threat, people create their own perceptions of their illness, which 
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influence their response to illness. One aspect of illness perceptions includes perceived 
control over the condition: a lack of perceived control can result in a sense of helplessness 
(Abramson, Seligman, & Teasdale, 1978). Additionally, RA-cognitions can relate to an 
individual’s self-efficacy, or their assessment of whether they have the resources to be able to 
manage prospective situations (Bandura, 1977). 
The results of the box-analysis of RA-related cognitions are shown in Table 2. At a cross-
sectional bivariate level, 88.9% (16/18) analyses yielded significant associations. Increased 
levels of fatigue were associated with reduced general self-efficacy (r=-0.30, r=-0.44) as well 
as reduced efficacy over pain (r=-0.54), other symptoms (r=-0.30; r=-0.52), function (r=-
0.45) and RA coping (r=-0.47), increased levels of helplessness (rs= -0.32-0.49), perceptions 
of the disease being uncontrollable/incurable (r=-0.20), as having significant consequences 
(r=0.33), and reduced illness acceptance (r=-0.49). Rezvani et al., (2012) found an 
association between illness perceptions and fatigue (r= 0.55, p<0.001), however did not 
clarify which specific illness perceptions were associated with fatigue.  Mixed evidence was 
found for the perceptions of medication beliefs and concerns about medication. Treharne et 
al. (2005) examined fatigue in relation to beliefs about RA medication and found no 
significant association between perceptions of medication necessity nor medication concerns 
and fatigue (rs = 0.12 and 0.16 respectively). These findings are at odds with Neame & 
Hammond (2005) who found that concerns about medication (r=0.29, p<0.001) and beliefs 
about medication necessity(r=0.30, p<0.001) were significantly associated with increased 
fatigue. 
At a multivariate level, relationships between general self-efficacy and coping self-efficacy 
were sustained after adjusting for several covariates. Cross et al. (2008) created regression 
models including the variables: comorbidities, physical and mental aspect of QoL, pain, 
stiffness, function, disability, and mental health. Reduced levels of self-efficacy for other 
symptoms remained a significant predictor of increased fatigue when measured by the 
Fatigue Severity Scale (FSS; Neuberger, 2003) (=-0.44, p<0.01). The entire model 
(including vitality and other symptom self-efficacy) accounted for 48% of the variance in 
FSS fatigue severity. Riemsma et al. (1998) performed a stepwise multiple regression 
analysis including gender, disease duration, health status, physical function, pain, affect, 
social support and social mobilisation found that RA self-efficacy remained a significant 
predictor of increased fatigue, accounting for 33% of the variance in fatigue (B=-4.89, 
p<0.01).  
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Very few RA-related cognitions were measured longitudinally, however where they were, 
they were universally found to be associated with fatigue in both bivariate and multivariate 
analyses. Treharne et al. (2008) used the Illness Perception Questionnaire (IPQ; Weinman, 
Petrie, Moss-Morris, & Horne, 1996) to measure patients’ perceptions of RA consequences, 
and the Arthritis Self-Efficacy Scale (ASES; Lorig, Chastain, Ung, Shoor, & Holman, 1989) 
to measure perceived self-efficacy over other symptoms of RA, such as fatigue and mood. 
Both increased perceptions of consequences and reduced self-efficacy were found to be 
significantly correlated with higher levels of fatigue both at baseline (0.32, -0.42, ps<0.001 
respectively) and at 1-year follow-up (0.40, -0.36, ps<0.001 respectively). Five hierarchical 
linear regression models were created, including an increasing number of variables. 
Perceptions of consequences and self-efficacy were entered in the final two models, and in 
the final model, also including age, gender, employment status, disease duration, medication, 
inflammation, pain, disability impact, sleep disruption, depressed mood, and coping, both 
perceptions of consequences (= 0.30, p<0.05) and self-efficacy (= -0.27, p=0.06) at 
baseline remained significant predictors of fatigue at 1-year follow-up, showing the largest 
coefficient sizes in the model. Baseline perceptions of illness consequences and self-efficacy 
explained 9% of the variance in fatigue at 1-year follow-up.  
Examination of the quality synthesis in Table 3 shows the mixed level of quality seen in the 
studies examining RA-related cognitions. A total of 91.7% used validated measures of 
psychological variables, however only 50% used validated measurements of fatigue and 
reported eligibility criteria. Only 33.3% of studies used randomised/consecutive recruitment 
strategies, and the same number recruited patients from multiple centres. Only 16.7% 
reported a participation rate of >75% and specifically stated that they had sufficient power for 
their analysis. 
Non-RA-related cognitions 
Four studies examined a range of non-RA-related cognitions, such as goal ownership, role 
satisfaction, and self-efficacy not related specifically to RA. Distorted or maladaptive 
perceptions may inhibit effective management of fatigue, and thus contribute to the 
perpetuation of fatigue symptoms (Tack, 1990).  
The results of the box-analysis of non-RA-related cognitions are shown in Table 2. The 
cross-sectional bivariate analyses show that in 100% of results, a significant association was 
found. Increased levels of fatigue were associated with reduced role satisfaction (r=-0.40), 
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reduced fatigue self-efficacy (r=-0.46), reduced somatic fatigue causal attributions (r=-0.26), 
increased non-somatic fatigue causal attributions (r=0.14), increased fatigue catastrophizing 
rumination (r=0.31), helplessness (r=0.39) and magnification (r=0.21).  
After adjusting for covariates in multivariate analyses, significant associations were found 
between fatigue self-efficacy, fatigue magnification catastrophizing, and social mobilisation 
self-efficacy and fatigue. Riemsma et al. (1998) assessed 229 outpatients’ perceptions of 
social mobilisation; their expectations regarding capability to obtain help from their social 
network if needed. A stepwise multiple regression analysis including gender, disease 
duration, physical function, pain, affect, social support and RA coping self-efficacy found 
that reduced social mobilisation self-efficacy remained a significant predictor of increased 
fatigue (B=-4.54, =-0.17, p<0.01), predicting approximately 36% of the variance in fatigue.  
Van Hoogmoed et al. (2010) used the SES-28 to measure fatigue self-efficacy and found it to 
be significantly associated with fatigue both at bivariate level, and also after a chunk-wise 
backward regression analysis (β=-0.20, p<0.001). Additionally, the magnification element of 
fatigue catastrophizing remained a significant predictor of fatigue in the final model (β=-0.11, 
p<0.05). The final model (including age, Rheumatoid Factor status, pain, physical function, 
depressive thoughts, fatigue self-efficacy, worrying, magnification of fatigue and sleep 
disturbances) accounted for 63% of the variance in fatigue. 
In the longitudinal studies at a bivariate level, increased fatigue at follow-up was found to be 
associated with reduced role satisfaction and fatigue self-efficacy at baseline. At a 
multivariate level, reduced goal ownership and fatigue self-efficacy at baseline were 
associated with increased fatigue at follow-up, although role satisfaction lost its association 
with fatigue. Maes et al. (2006) used the Treatment Self-Regulation Questionnaire (TSRQ; 
Levesque et al., 2007) to assess goal ownership, and found that it significantly predicted 
fatigue at one-year follow-up, after controlling for socio-demographic and disease variables 
in a hierarchical regression analysis. Strengthening perceptions of goal ownership may help 
to reduce fatigue in RA. Mancuso et al. (2006) examined perceptions of role satisfaction and 
found that reduced role satisfaction at baseline was correlated with increased fatigue at one-
year follow-up (r=0.37, p<0.001). However in a multivariate model including gender, age, 
comorbidities, mood, disability, social support, pain, sleep quality, physical activity and 
disease variables, perceived role satisfaction was no longer associated with fatigue at follow-
up. 
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Assessment of study quality reveals fairly poor study quality in the small number of papers 
examining non-RA-related cognitions. A total of 66.7% used validated measures for 
psychological variables ad fatigue, and stated eligibility criteria. None of the studies used 
randomised/consecutive recruitment strategies, multi-centre recruitment, stated a 
participation rate of >75% or stipulated that they were adequately powered for their analysis.  
Personality Traits 
Several models of fatigue suggest that certain personality traits, notably perfectionist 
tendencies and neuroticism (Surawy, Hackmann, Hawton, & Sharpe, 1995), may pre-dispose 
individuals to develop fatigue disorders, and that traits such as extraversion may be protective 
against fatigue (Michielsen, De Vries, & Van Heck, 2003). Four studies examined the role of 
three personality traits on fatigue: neuroticism, optimism and self-consciousness. 
The results of the box-analysis of personality traits are shown in Table 2. Only 50% of 
bivariate analyses revealed fatigue to be significantly associated with personality traits. 
Increased levels of fatigue were found to be associated with increased neuroticism (r=0.44), 
and increased public self-consciousness (r=0.22). Mixed evidence was found for the 
relationships between optimism and fatigue.  
At a multivariate level, only public self-consciousness was found to be associated with 
fatigue. Treharne et al. (2005) performed a multivariate analyses taking into account 
demographics, psychosocial variables and disease duration were created to examine the main 
effects of these variables on fatigue. Fatigue was found to be lower in patients with low 
public self-consciousness (M= 41.5, SD= 24.2) than in those with high public self-
consciousness (M=53.9, SD= 22.9; F(1,76) = 7.1, p<0.01).  
Only neuroticism was examined with any element of follow-up. Stone et al. (1997) examined 
neuroticism in relation to fatigue in Ecological Momentary Assessment, looking at diurnal 
cycles and within-day fatigue variation, however it was not found to be significantly 
associated with variability of fatigue throughout the day. 
Quality assessment, shown in Table 3, shows that in general, study quality in this group was 
higher than in other categories. 100% of studies used validated assessments of personality, 
and 75% used validated fatigue assessments. 75% reported eligibility criteria, and 50% 
recruited from multiple site. 25% reported a participation rate >75%, however no studies used 
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randomised/consecutive recruitment strategies, or stated if they were sufficiently powered for 
their analysis.  
Stress and Coping 
Increased stress is thought to be associated with increased levels of fatigue in RA, through the 
increased stimulation of interleukin-6 caused by stress, which in turn, is associated with 
increased levels of fatigue (Davis et al., 2008). Not only the increase in perceived stress, but 
also the coping mechanisms used to manage stress may therefore be crucially associated with 
fatigue in RA. Five studies examined the relationships between stress and coping and fatigue.  
At a cross-sectional, bivariate level (Table2), 77.8% of studies reported a significant 
association between stress and coping variables and fatigue. Increased fatigue was associated 
with increased levels of stress/hassles (rs= 0.43, 0.37, 0.39), increased worrying coping 
(r=0.49), retreating coping (r=0.22), resting coping (r=0.19), and fatigue transformation 
coping (r=0.23), reducing demands (r=0.22). No significant bivariate associations were found 
between general coping strategies and fatigue, nor praying/hoping coping or distraction 
coping and fatigue. In multivariate analysis, only worrying coping retained its significant 
association with fatigue (=-0.21, p<0.05; van Hoogmoed et al., 2010). 
In longitudinal analyses, no stress/coping variables were found to be associated with fatigue 
either at bivariate or multivariate level. Treharne et al. (2008) examined praying/hoping 
coping strategies in 114 patients with RA. In a correlation analysis, baseline coping was not 
significantly associated with fatigue at either baseline (r=0.19, p>0.05) or at 1-year follow-up 
(r=0.04, p>0.05). When included in a hierarchical linear regression model, also including 
several demographic, psychological and disease variables, coping was not predictive of 
fatigue at one-year follow-up (=-0.04, p>0.05). 
Assessment of study quality (table 3) shows that 100% and 60% of these studies used 
validated measures of stress/coping variables and fatigue respectively. Only 20% used 
randomised or consecutive recruiting strategies, and 40% recruited from multiple sites. All of 
the studies (100%) reported eligibility criteria, however a vast minority (20%) had adequate 
levels of participation or stated that they were well-powered for their analysis.  
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Social Support and Interpersonal Relationships 
The extent to which an individual feels that they have sufficient support and assistance 
available if required may be a crucial aspect in the management of fatigue in RA; it can assist 
in the self-management of the condition, adherence to medication and recommended lifestyle 
changes (Taal, Rasker, Seydel, & Wiegman, 1993). However social support is not always 
positive. Problematic, unwanted or stressful interpersonal relationships may result in 
increased stress, depression and fatigue in RA (Revenson, Schiaffino, Majerovitz, & 
Gibofsky, 1991). Therefore it is not only the quantity of social support which is important, 
but also the quality of that social support. Seven studies examined the relationship between 
social support and fatigue.  
At a cross-section bivariate level (table 2), 66.7% of analyses found significant assocaitions 
between social support and fatigue. Increased fatigue was found to be associated with 
reduced perceived quantity of social support (rs=-0.26 and -0.24 ) and increased problematic 
social support (rs=0.14 and 0.28). Mixed evidence was found for perceived adequacy of 
social support.  
In the multivariate analyses, only two analyses continued to find social support (problematic) 
to be associated with fatigue. Riemsma et al. (1998) measured both social support and 
problematic social support in 229 RA outpatients. Increased problematic social support 
remained a significant predictor of fatigue when included in a multiple regression analysis 
including gender, disease duration, physical function, pain, affect and self-efficacy (B= 4.64, 
=0.13, p<0.05), accounting for 37% of the variance in fatigue in total.  
Mixed evidence was found for positive and negative interpersonal events, both in same-day 
and next-day assessments of fatigue. Davis, Okun, Kruszewski, Zautra, & Tennen (2010) 
examined the relationship between daily interpersonal events and same- and next-day fatigue. 
They report that a higher than average number of negative interpersonal events was 
associated with increased levels of same-day fatigue. Changes in positive interpersonal events 
were associated with reduced fatigue in women, but not men. However this interaction 
became non-significant after controlling for affect. The relationship between the interaction 
between positive interpersonal events and female gender and same day fatigue was found to 
be mediated by positive affect. Similarly, changes in negative interpersonal events and same-
day fatigue was found to be mediated by negative affect. Same-day fatigue and number of 
negative interpersonal events were strong predictors of next-day fatigue. There was a 
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significant interaction between gender and interpersonal events, whereby days with increased 
positive interpersonal experiences were associated with higher levels of next-day fatigue for 
women but not men. Negative affect was also found to partially mediate the pathway between 
negative interpersonal events and next-day fatigue.  
No other significant associations were found in longitudinal assessments of fatigue and social 
support. Mancuso et al. (2006) used the Duke Social Support and Stress Scale (Parkerson, 
Broadhead, & Tse, 1991) to examine perceived social support and stress and their 
associations with long-term fatigue. After controlling for other psychosocial and disease 
variables. At one-year follow-up, neither baseline social stress (r=0.19, p=0.07) nor social 
support (r=0.16, p=0.13) were associated with fatigue in bivariate or multivariate analysis.   
The association between social support and fatigue is varied. There is some evidence to 
suggest that negative or problematic social support is associated with poorer fatigue 
outcomes, and that positive social support is associated with reduced fatigue. However the 
limited number of studies prevents solid conclusions being formed. Assessment of study 
quality shows that 100% of studies used a validated measure of social support, and 57.1% a 
validated measure of fatigue. Only 14.3% used randomised/consecutive reporting strategies, 
and 42.9% recruited from multiple centres. In total, 85.7% stated their eligibility criteria, and 
14.3% reported a participation rate of >75%. No studies stated whether they were adequately 
powered for their analysis.  
Discussion  
Summary of findings 
The aim of this review was to identify studies of psychological variables and their 
associations with fatigue in RA. A systematic search of the literature revealed several 
psychological correlates of fatigue which were grouped into six categories: affect and 
common mental disorders, RA-related cognitions, non-RA related cognitions, personality 
traits, stress and coping, and social support and interpersonal relationships.  
There was some evidence to support the link between mood and fatigue, with many studies 
finding an association between low mood and higher levels of fatigue. However at a 
multivariate level, several studies show non-significant associations. Whilst mood may be 
related to fatigue, its collinearity with other variables such as increased pain perception  
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Table 3. Quality assessment for combined analysis of specific 
variables                     
Category 
Validated 
measure of 
psychological 
variable? 
 
Multi-item 
measure of 
fatigue? 
 
Randomised
/consecutive 
recruitment 
strategy? 
 Multi-
centre? 
 
Eligibility 
criteria 
specified? 
 
Participat
ion rate 
>75% 
 Adequately 
powered? 
  Yes   Yes   Yes   Yes   Yes   Yes   Yes 
Affect and common mental 
disorder (N=25) 76.0% 
 
52.0% 
 
32.0% 
 
36.0% 
 
80.0% 
 
36.0% 
 
20.0% 
RA-related cognitions (N=12) 
91.7% 
 
50.0% 
 
33.3% 
 
33.3% 
 
50.0% 
 
16.7% 
 
16.7% 
Non-RA-related cognitions (N=3) 
66.7% 
 
66.7% 
 
0.0% 
 
0.0% 
 
66.7% 
 
0.0% 
 
0.0% 
Personality Traits (N=4) 
100.0% 
 
75.0% 
 
0.0% 
 
50.0% 
 
75.0% 
 
25.0% 
 
0.0% 
Stress and Coping (N=5) 
100.0% 
 
60.0% 
 
20.0% 
 
40.0% 
 
100.0% 
 
20.0% 
 
20.0% 
Social Support and Interpersonal 
relationships (N=7) 100.0% 
 
57.1% 
 
14.3% 
 
42.9% 
 
85.7% 
 
14.3% 
 
0.0% 
Total 79.3%   48.3%   31.0%   37.9%   72.4%   31.0%   30.7% 
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(Dickens, McGowan, & Dale, 2003), inflammation (Howren, Lamkin, & Suls, 2009) and 
other socioeconomic variables (Lorant et al., 2003) may dilute its influence on multivariate 
analyses. Similarly, there was relatively consistent evidence that RA-related cognitions were 
related to fatigue, for example, reduced self-efficacy was associated with increased fatigue. 
Although limited in number, longitudinal studies reveal a potentially persistent association 
between RA cognitions (self-efficacy for other symptoms and perceptions of illness 
consequences) and fatigue over time. Moreover, several studies suggested that non-RA 
related cognitions (such as fatigue self-efficacy and goal ownership) were associated with 
fatigue, although again, these relationships were often not sustained at a multivariate level. 
The review found no conclusive evidence for an association between personality traits and 
fatigue. Fairly consistent bivariate associations were found between stress/coping and fatigue, 
however these were not supported in multivariate analyses and longitudinal designs. 
Inconsistent evidence was found relating social support and fatigue, highlighting the complex 
nature of social support in relation to health: there are elements of reverse causality whereby 
the existence of fatigue may in itself alter both perceptions and availability of social support; 
personality factors such as neuroticism or hostility may confound relationships between 
social support and health; and there are pertinent cultural and personal differences in 
perceptions of “adequate” social support quality and quantity (Thoits, 2011).  
Importantly, the results of our study suggest that disease-related factors such as disease 
activity, pain, physical function, medication and stiffness play an important role in fatigue 
levels. In some of the included studies, we found that psychological variables (such as 
anxiety, depression, helplessness, life stress, and coping) were no longer significantly 
associated with fatigue after controlling for disease related factors.  Disease activity appears 
to play a role in the relationship between psychological variables and fatigue, however further 
research and similar systematic review methodology is needed in order to identify whether 
disease activity acts as a mediator.  
Similarly, self-efficacy also appears to be an important factor in the relationship between 
fatigue and mood. In two of the included studies, the association between fatigue and mood 
became non-significant after controlling for self-efficacy (Riemsma et al., 1998). However, 
as neither of the studies were prospective, it was not possible to ascertain whether self-
efficacy acted as a mediator. 
31 
 
A cognitive behavioural model of fatigue in RA  
Hewlett et al’s (2011b) model of fatigue in RA suggested that there is an interaction between 
RA-related factors, cognitive-behavioural factors, and personal factors, which interact to 
maintain fatigue. This review sought to systematically review and synthesise the evidence 
base for the psychological components of fatigue, and consequently we propose a 
psychological model of fatigue in RA (Figure 3). This is consistent with  cognitive-
behavioural models of fatigue in other illnesses such as chronic fatigue syndrome (Surawy et 
al., 1995; Chalder, Butler, & Wessely, 1996) and cancer (Armes, Chalder, Addington-Hall, & 
Hotopf, 2007). The onset of fatigue may be associated with a trigger (such as inflammation), 
and fatigue then develops and is maintained over time by disease activity but also factors 
such as low affect, unhelpful cognitions, avoidant coping and lack of social support, which 
interact with each other. People may find themselves in a vicious circle in which they do not 
have the self-efficacy to break. For example, a perception of RA as being uncontrollable or 
having serious consequences may lead an individual to reduce their activities in an attempt to 
control the symptoms but which has the unfortunate consequence of making the fatigue 
worse. Similarly, cognitions that are not specific to RA, such as fatigue self-efficacy, fatigue 
catastrophising and role satisfaction, may contribute to fatigue. In addition, unwelcome or 
unwanted social input may increase fatigue levels. Conversely, high levels of RA-self-
efficacy, illness acceptance and positive social support may help an individual to manage 
fatigue levels more effectively.  
Rigorous and systematic assessment of the disease-related and environmental variables 
suggested by Hewlett et al. (2011b) would further contribute to strengthening a holistic model 
of fatigue in RA.  
Strengths and limitations  
A strength of this review is that it was conducted using a rigorous and replicable 
methodology, with abstract screening and data extraction being carried out by independent 
researchers in order to reduce bias.  
However this review also has some limitations. It is possible that it could have been 
influenced by publication bias. As the broad scope of this review, and vast heterogeneity both 
between and within psychological categories precluded a meta-analysis, it was not possible to 
formally assess the extent of publication bias using a funnel plot or sensitivity analysis. In 
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future reviews, it may be beneficial to include ‘grey literature’, as this is more likely to report 
negative findings and therefore give a more balanced view of the literature. The quality of the 
included studies was varied. Both cross-sectional and prospective studies were included, 
although the majority of studies were cross-sectional. Therefore there was a limit to the 
conclusions that could be drawn about cause and effect. The measures used in this study were 
heterogeneous and varied between visual analogue scales and multi-item psychometric 
scales. The majority of measures however had been validated. Many of the disease-related 
factors examined in this review (such as pain, physical activity, and disease severity) were 
self-reported. It is likely that objective measurements give a more robust representation of 
disease activity than self-report measures. Mood may act as a confounder for self-reported 
measures of disease activity (Ward, 1994), and self-reported disease activity could potentially 
be over-reported in patients who are experiencing depression or fatigue.  
Although most studies used an appropriate statistical method for analysing the data many 
studies did not account for the presence of confounding variables during the analysis. Many 
studies did not provide a sample size calculation or power analysis in order to justify the size 
of their sample. Also, very few studies reported data on retention rates and the completeness 
of follow up. The majority of studies described detailed demographic sample characteristics 
such as gender, age and disease duration, although many did not specify details such as 
ethnicity or socio-economic status. Therefore it is difficult to assess the representativeness of 
these samples. Only around two thirds of the included studies reported a recruitment strategy. 
Of these, the majority used consecutive sampling and convenience sampling from outpatient 
clinics. An advantage of this kind of sampling is that it is less vulnerable to selection bias 
because the participants are likely to be less selected than in randomised controlled trials. 
However, very few of the included studies described their inclusion and exclusion criteria. 
Therefore it was not possible to assess for the presence of selection bias.  
A further consideration is the measurement of such complex psychological variables. 
Personality is a complex and challenging construct, often measured according to the “Big 
Five” traits: extraversion, agreeableness, conscientiousness, neuroticism, and openness to 
experience (Goldberg, 1990). However a focus on the Big Five may result in the omission of 
several other traits which may influence health and well-being. Cloninger and Zohar (2012) 
for example, report that self-directedness, cooperativeness and self-transcendence are all 
associated with well-being. The results of the current review also suggest that self-
consciousness may be an important construct. Establishing the impact of personality on  
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Figure 3. A conceptual model of fatigue in rheumatoid arthritis based on research evidence  
Footnote: Bidirectional arrows represent evidence-based associations between variables as found in this review. Factors with a greater weight of evidence are shown in bold. Dotted boxes 
indicate fields where further systematic review evidence is needed. Hypothesised variables are indicated using shaded boxes.  
34 
 
health outcomes is challenging to determine due to the interrelatedness between personality 
traits. Single-trait questionnaires such as the Life Orientation Test may be insufficient to 
capture the complexity of personality, and make it challenging to determine whether a 
personality trait is independent, works interactively with other traits to impact health, or is 
redundant (Korotkov & Hannah, 2004). Our conclusions relating to personality and fatigue 
are therefore limited by a small quantity of studies, focused on independent traits, rather than 
the broader spectrum of personality.  
Clinical implications  
The findings of this review have many clinical implications. For example, although fatigue is 
commonly reported in RA patients, it is not consistently measured as an outcome in clinical 
studies of RA (Kalyoncu et al., 2009). It has been suggested that all studies of RA should 
include fatigue as a routine outcome variable, because of its significance to patients and its 
responsiveness to treatment (Kirwan et al., 2007). Fatigue can be assessed when patients first 
present to primary and secondary care, and continually monitored throughout the course of 
treatment. Early identification and management may prevent acute fatigue from becoming 
chronic.  
The results of this review suggest that fatigue is correlated with several psychological factors 
which are amenable to change (Cramp et al., 2013).  Motivational interviewing could be used 
to foster motivation and encourage people with RA to change health behaviours, such as 
physical activity (Bode et al., 2008; Hurkmans et al., 2010). Healthcare staff at rheumatology 
clinics could be trained to deliver minimal interventions based on cognitive behavioural 
approaches, therefore helping patients to self-manage the disease (Dures & Hewlett, 2012). 
Brief interventions may provide a preferable, more accessible and cost-effective solution to 
the treatment of fatigue compared to traditional Cognitive Behavioural Therapy (CBT).  
Our model highlights the importance of mood and affect on fatigue levels in RA and research 
suggests that depression is highly prevalent in RA patients (Matcham, Rayner, Steer & 
Hotopf, 2013). Psychological or pharmacological treatment of emotional symptoms may have 
a beneficial effect on fatigue levels. More specifically, non-pharmacological interventions 
such as cognitive behavioural therapy, relaxation and stress-management may be useful 
additions to traditional medical treatments for mood disorders in RA (Cramp et al., 2013).  
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Cognitive-behavioural approaches to managing rheumatic diseases often include recognising 
links between cognitions, behaviours and symptoms and using strategies such as self-
monitoring, cognitive restructuring, relaxation, and goal setting to help patients self-manage 
their illness (Dures & Hewlett, 2012). There is some evidence that CBT for RA can lead to 
positive outcomes such as improved coping, well-being and self-efficacy, as well as reduced 
fatigue and depression (Sharpe, Sensky, Timberlake, Ryan, Brewin & Allard, 2001; Evers, 
Kraaimaat, van Riel & de Jong, 2002; Hammond, Bryan, & Hardy, 2008; Hewlett et al., 
2011a).  
RA interventions that are not targeted specifically towards fatigue but focus on ameliorating 
disease related factors directly, can lead to a reduction in fatigue (Hewlett et al., 2011a). 
Indeed, our review showed that disease-related factors were associated with fatigue, and 
therefore targeting specific disease related factors may help to reduce symptoms of fatigue. 
For example, disease-modifying drugs and anti-TNF drugs have been shown to reduce 
fatigue in people with RA (Pollard et al., 2006). 
Recommendations for future research  
Based on the quality assessment of the studies included in this review, we can offer some 
recommendations for future studies of psychological correlates of fatigue in RA.  
Firstly, studies should have a prospective design so that causal associations and mediators can 
be examined (for example, using multiple regression analysis). The sample size should be 
large enough for a well-powered statistical analysis, and to account for attrition during the 
course of the study.  
In order to reduce selection bias, participants should be recruited consecutively from primary 
or secondary care, and reasons for exclusion should be clearly stated. Ideally, patients would 
all be at the same stage of disease so that disease duration can be controlled for. The study 
should also take into account any treatment the patient has had.  
A model of understanding fatigue in the context of RA should be based on previous theory 
and evidence taking account of biological, psychological and social factors.  When 
conducting new research the choice of measures should then be guided by the model. In 
addition, disease activity should be assessed using both objective and subjective measures 
and controlled for when measuring the association between psycho-social variables and 
fatigue.  
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Future studies could investigate the effectiveness of targeted interventions for fatigue in RA. 
A randomised controlled trial design could be used in order to investigate the effectiveness of 
CBT as compared to treatment as usual. Several measures of fatigue could be used in order to 
capture the multidimensionality of fatigue. Additionally, psychological variables such as, 
unhelpful thoughts and avoidance behaviour which may play a role in the maintenance of 
fatigue could be examined as possible mediators.  
Conclusions 
This review has shown that fatigue in RA is associated with a number of psychological, 
social and disease-related factors. These relationships have been illustrated in the form of a 
cognitive-behavioural model of fatigue in RA. Longitudinal studies are needed in order to 
understand the nature of fatigue in RA and any causal relationships with psycho-social 
factors. Individuals with RA fatigue may benefit from pharmacological and psychological 
interventions which target these factors. 
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